Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC
- Resource Type
- Article
- Source
- In
European Journal of Medicinal Chemistry 5 January 2024 263 - Subject
- Language
- ISSN
- 0223-5234